Patent · US Active

Device for detection of hepatocellar carcinoma (HCC) using an octanoate breath test

US10307140B2 · kind B2 · utility

0Cited by
7References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2017
Grant dateJun 4, 2019
Priority date
Expiry dateDec 16, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2458/15
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and systems for diagnosis, prognosis and monitoring of hepatocellular carcinoma (HCC). Specifically, the present invention relates to the use of breath tests based on isotope-labeled octanoate in the detection and monitoring of HCC.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.